US Equity
OMER
— OMEROS CORPORATIONOmeros Corporation is a biopharmaceutical company that discovers, develops, and commercializes small-molecule and protein therapeutics for inflammation, immune-related diseases, and ophthalmology.
💰 Market cap: $820.74M📍 201 Elliott Avenue West, SEATTLE, WA, 98119 US🏷️ Biotechnology & Medical Research💵 Previous close: $9.79🔢 9,756 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $9.79 |
| 2026-07-23 | $10.28 |
| 2026-07-22 | $9.84 |
| 2026-07-21 | $9.53 |
| 2026-07-20 | $9.63 |
| 2026-07-17 | $9.69 |
| 2026-07-16 | $9.22 |
| 2026-07-15 | $10.37 |
| 2026-07-14 | $10.50 |
| 2026-07-13 | $10.01 |
| 2026-07-10 | $10.28 |
| 2026-07-09 | $10.27 |
| 2026-07-08 | $10.24 |
| 2026-07-07 | $10.33 |
| 2026-07-06 | $10.34 |
| 2026-07-02 | $9.28 |
| 2026-07-01 | $9.41 |
| 2026-06-30 | $9.51 |
| 2026-06-29 | $9.91 |
| 2026-06-26 | $8.67 |
| 2026-06-25 | $10.72 |
| 2026-06-24 | $10.58 |
| 2026-06-23 | $10.48 |
| 2026-06-22 | $10.33 |
| 2026-06-18 | $10.28 |
| 2026-06-17 | $9.64 |
| 2026-06-16 | $9.48 |
| 2026-06-15 | $9.33 |
| 2026-06-12 | $8.73 |
| 2026-06-11 | $10.18 |
| 2026-06-10 | $10.20 |
| 2026-06-09 | $9.97 |
| 2026-06-08 | $9.85 |
| 2026-06-05 | $9.79 |
| 2026-06-04 | $10.25 |
| 2026-06-03 | $10.16 |
| 2026-06-02 | $10.26 |
| 2026-06-01 | $10.72 |
| 2026-05-29 | $11.04 |
| 2026-05-28 | $11.15 |
| 2026-05-27 | $11.07 |
| 2026-05-26 | $11.65 |
| 2026-05-22 | $11.46 |
| 2026-05-21 | $11.96 |
| 2026-05-20 | $12.38 |
| 2026-05-19 | $11.97 |
| 2026-05-18 | $11.70 |
| 2026-05-15 | $12.25 |
| 2026-05-14 | $13.28 |
| 2026-05-13 | $14.38 |
| 2026-05-12 | $14.76 |
| 2026-05-11 | $14.36 |
| 2026-05-08 | $14.13 |
| 2026-05-07 | $14.64 |
| 2026-05-06 | $14.83 |
| 2026-05-05 | $14.77 |
| 2026-05-04 | $14.91 |
| 2026-05-01 | $15.06 |
| 2026-04-30 | $14.60 |
| 2026-04-29 | $14.56 |
| 2026-04-28 | $14.67 |